In: Intensive Care Medicine, 2015, vol. 41, no. 4, p. 719-720
|
In: International Archives of Occupational and Environmental Health, 2015, vol. 88, no. 2, p. 175-184
|
In: Neurosurgical Review, 2015, vol. 38, no. 2, p. 265-272
|
In: Lung, 2015, vol. 193, no. 1, p. 113-120
|
In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 27, no. 3, p. 427-436
|
In: Neurocritical Care, 2015, vol. 22, no. 3, p. 403-408
|
In: Intensive Care Medicine, 2015, vol. 41, no. 5, p. 936-938
|
In: Journal of General Internal Medicine, 2015, vol. 30, no. 1, p. 17-24
|
In: Value in Health, 2019, vol. 22, no. 12, p. 1355–1361
Elderly patients receive bare metal stents instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT). The SENIOR trial compared outcomes between these 2 types of stents combined with a short duration of DAPT. A significant decrease in the number of patients with at least 1 major adverse cardiac and cerebrovascular event (MACCE) was noted in the DES...
|
In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582
Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...
|